Skip to main content
. 2020 May 29;13(5):882–890. doi: 10.1007/s12328-020-01142-3

Table 3.

Characteristics of patients with spur cell anemia

No Age Sex Etiology Child–Pugh score MELD score Hemoglobin (g/dL) Treatment Prognosis References
1 26 M Alcohol 11 24 2.1 Blood transfusion, albumin infusion, plasma diafiltration, diuretics, intubation Doing well for a year Our case
2 31 M Alcohol NA NA 9.0 Blood transfusion Succumbed in 2 weeks [23]
3 52 M Alcohol 12 29 7.9 Blood transfusion, plasmapheresis, albumin infusion Discharged [24]
4 64 M NAFLD 10 NA 6.6 High-dose steroids, dialysis Discharged [25]
5 9 F Wilson's disease NA NA 8.9 NA Succumbed within 10 days [19]
6 44 M Alcohol 11 27 7.4 NA Waiting for LT [26]
7 47 F Alcohol NA NA NA Blood transfusion NA [27]
8 44 F PBC/AIH overlap NA 30 9.0 Blood transfusion, plasmapheresis Waiting for LT [28]
9 60 M Alcohol NA 38 6.1 Blood transfusion Succumbed in 5-months [29]
10 32 F Alcohol, HCV NA NA 6.2 Blood transfusion Waiting for LT [30]
11 56 F NA NA NA 6.8 Blood transfusion Succumbed [31]
12 61 F PBC NA NA 6.2 NA NA [20]
13 34 M Alcohol NA NA NA LT Doing well [13]
14 17 F Biliary atresia NA NA 5.7 LT Doing well [14]
15 47 M Alcohol NA NA 7.3 Blood transfusion Waiting for LT [32]
16 43 F Alcohol NA 40 11.2 NA Succumbed in 2-months [33]
17 48 M NA NA NA 7.7 NA Succumbed before LT [34]
18 30 M Alcohol NA NA 7.7 Flunarizine, pentoxifylline, cholestyramine Recovery of anemia [35]
19 41 F Alcohol NA NA 8.4 Diuretics Lost of follow-up [36]
20 31 M Alcohol NA NA NA LT Doing well a year later [16]
21 53 M Alcohol NA NA 8.5 LT Recovery of anemia [37]
22 44 F Alcohol NA NA 9.0 LT Doing well 3-months later [37]
23 49 M Alcohol NA NA NA NA NA [38]
24 52 M Alcohol NA NA 7.9 NA Succumbed [39]
25 47 F Alcohol NA NA 6.2 Flunarizine Recovery of anemia [40]
26 45 F Alcohol NA NA 8.3 Flunarizine ND [40]

AIIH autoimmune hepatitis, HCV hepatitis C virus, F female, LT liver transplantation, M male, MELD Model for End-Stage Liver Disease, NA not available, NAFLD non-alcoholic fatty liver disease, PBC primary biliary cholangitis